This inventor holds 4 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignees: Chdi Foundation, Inc., Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals, Inc.. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 56 
1 out of 207 
1 out of 1,482 
Years Active: 2011-2026
Title: Douglas Macdonald: Innovator in Pharmaceutical Science
Introduction
Douglas Macdonald is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of pharmaceutical science, particularly in the development of treatments for neurodegenerative disorders. With a total of 4 patents, his work focuses on innovative methods and compositions that address critical health issues.
Latest Patents
Among his latest patents, Douglas Macdonald has developed transglutaminase TG2 inhibitors, which include pharmaceutical compositions and methods of use. These patents provide certain compounds and pharmaceutically acceptable salts, along with pharmaceutical compositions that comprise at least one of these compounds. His work describes methods for treating patients suffering from disease states responsive to the inhibition of transglutaminase TG2 activity, including neurodegenerative disorders such as Huntington's disease. The methods of treatment involve administering these compounds either as a single active agent or in combination with other therapeutic agents.
Career Highlights
Throughout his career, Douglas Macdonald has worked with prominent organizations in the pharmaceutical industry. Notable companies include the CHDI Foundation, Inc. and Aventis Pharmaceuticals Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Some of his notable coworkers include Michael Edward Prime and Stephen Martin Courtney. Their collaborative efforts have likely enhanced the impact of his research and inventions in the pharmaceutical field.
Conclusion
Douglas Macdonald's contributions to pharmaceutical science, particularly in the area of neurodegenerative disorders, highlight his innovative spirit and dedication to improving patient care. His patents and collaborations reflect a commitment to advancing medical treatments that can significantly benefit those in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile